A systematic comparison of pharmacogene star allele calling bioinformatics algorithms: a focus on CYP2D6 genotyping D Twesigomwe, GEB Wright, BI Drögemöller, J Da Rocha, Z Lombard, ... NPJ genomic medicine 5 (1), 30, 2020 | 47 | 2020 |
StellarPGx: a nextflow pipeline for calling star alleles in cytochrome P450 genes D Twesigomwe, BI Drögemöller, GEB Wright, A Siddiqui, J da Rocha, ... Clinical Pharmacology & Therapeutics 110 (3), 741-749, 2021 | 40 | 2021 |
The extent and impact of variation in ADME genes in sub-Saharan African populations JEB Da Rocha, H Othman, G Botha, L Cottino, D Twesigomwe, S Ahmed, ... Frontiers in pharmacology 12, 634016, 2021 | 27 | 2021 |
Characterization of CYP2D6 Pharmacogenetic Variation in Sub‐Saharan African Populations D Twesigomwe, BI Drögemöller, GEB Wright, C Adebamowo, G Agongo, ... Clinical Pharmacology & Therapeutics 113 (3), 643-659, 2023 | 22 | 2023 |
Nanopore sequencing of 1000 Genomes Project samples to build a comprehensive catalog of human genetic variation JA Gustafson, SB Gibson, N Damaraju, MPG Zalusky, K Hoekzema, ... medRxiv, 2024 | 12 | 2024 |
Promoting Pharmacogenomics in Africa: Perspectives From Variation in G6PD and Other Pharmacogenes. BR Sitabule, H Othman, A Choudhury, D Twesigomwe, NA Hanchard Clinical Pharmacology & Therapeutics 113 (3), 2023 | 8 | 2023 |
Characterization of Novel CYP2D6 Alleles across Sub-Saharan African Populations WY Wang, D Twesigomwe, C Nofziger, AJ Turner, LS Helmecke, ... Journal of Personalized Medicine 12 (10), 1575, 2022 | 8 | 2022 |
Characterizing domain-specific open educational resources by linking ISCB Communities of Special Interest to Wikipedia AM Kilpatrick, F Rahman, A Anjum, S Shome, KMS Andalib, S Banik, ... Bioinformatics 38 (Supplement_1), i19-i27, 2022 | 4 | 2022 |
Characterization of CYP2B6 and CYP2A6 Pharmacogenetic Variation in Sub‐Saharan African Populations D Twesigomwe, BI Drögemöller, GEB Wright, C Adebamowo, G Agongo, ... Clinical Pharmacology & Therapeutics 115 (3), 576-594, 2024 | 3 | 2024 |
Characterization of POR Haplotype Distribution in African Populations and Comparison with Other Global Populations RP Booyse, D Twesigomwe, S Hazelhurst Pharmacogenomics 23 (14), 771-782, 2022 | 3 | 2022 |
PharmVar GeneFocus: CYP2A6 AWR Langlois, MJ Chenoweth, D Twesigomwe, G Scantamburlo, ... Clinical Pharmacology & Therapeutics 116 (4), 948-962, 2024 | 1 | 2024 |
High-coverage nanopore sequencing of samples from the 1000 Genomes Project to build a comprehensive catalog of human genetic variation JA Gustafson, SB Gibson, N Damaraju, MPG Zalusky, K Hoekzema, ... Genome Research, gr. 279273.124, 2024 | | 2024 |
The variation landscape of CYP2D6 in a multi-ethnic Asian population Y Maulana, R Toro Jimenez, D Twesigomwe, L Sani, A Irwanto, N Bertin, ... Scientific Reports 14 (1), 16725, 2024 | | 2024 |
Short-read full-length 16S rRNA amplicon sequencing for characterisation of the respiratory bacteriome of captive and free-ranging African elephants (Loxodonta africana) LC Martin, MA O’Hare, G Ghielmetti, D Twesigomwe, TJ Kerr, R Gumbo, ... Scientific Reports 14 (1), 14768, 2024 | | 2024 |
Characterisation of CYP2D6, CYP2B6 and CYP2A6 haplotype variation in African populations and development of the StellarPGx diplotype calling algorithm D Twesigomwe, Z Lombard, S Hazelhurst EUROPEAN JOURNAL OF HUMAN GENETICS 32, 692-693, 2024 | | 2024 |
Characterization of CYP2C19 Pharmacogenetic Variation in African Populations and Comparison with Other Global Populations RP Booyse, D Twesigomwe, S Hazelhurst Pharmacogenomics 24 (16), 845-857, 2023 | | 2023 |
Characterizing the combined effects of cytochrome P450 missense variation within star allele definitions N Khoza, D Twesigomwe, H Othman Pharmacogenomics 24 (10), 561-578, 2023 | | 2023 |
Characterisation of pharmacogene allelic variation in African populations and development of a novel diplotype calling algorithm D Twesigomwe | | 2022 |